Article
Role of Intratumoral Heterogeneity in Metastatic Progression and Drug Resistance
2025-04-27
Abstract excerpt
Metastatic cancer is the final frontier in disease progression with few avenues of treatment open to patients. The failure of therapeutic options at the end-stage disease is confounded by the presence of diverse clones in the metastatic tumor which contributes to intratumoral heterogeneity (ITH) resulting in intrinsic and acquired drug resistance. We aim to elucidate the contribution of ITH to the development of m...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3ce824ea-b929-5b95-b5a6-6fdeaa85d22f
- DOI
- 10.20944/preprints202504.1952.v1
